Microglial activation and intracerebral hemorrhage

  • Z. Gao
  • J. Wang
  • R. Thiex
  • A. D. Rogove
  • F. L. Heppner
  • S. E. Tsirka
Part of the Acta Neurochirurgica Supplementum book series (NEUROCHIRURGICA, volume 105)

Abstract

Introduction

Microglia activate upon injury, migrate to the injury site, proliferate locally, undergo morphological and gene expression changes, and phagocytose injured and dying cells. Cytokines and proteases secreted by these cells contribute to the injury and edema formed. We studied the injury outcome after local elimination/paralysis of microglia.

Methods

Adult male mice were subjected to intracerebral hemorrhage (ICH) by intra-caudate injection of either collagenase or autologous blood. Mice survived for different periods of time, and were subsequently evaluated for neurological deficits, size of the hematoma, and microglia activation. Mice expressing an fms-GFP transgene or the CD1 1b-HSVTK transgene were also used. For elimination of monocy-tes/macrophages, CD1 1b-HSVTK mice were treated with ganciclovir prior to hemorrhage. Modifiers of microglial activation were also used.

Results

Induction of ICH resulted in robust microglia activation and recruitment of macrophages. Inactivation of these cells, genetically or pharmacologically, pointed to a critical role of the time of such inactivation, indicating that their role is distinct at different time points following injury. Edema formation is decreased when microglia activation is inhibited, and neurological outcomes are improved.

Conclusions

Microglia, as immunomodulatory cells, have the ability to modify the final presentation of ICH.

Keywords

Microglia intracerebral hemorrhage edema tissue plasminogen activator 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Clark WM, Lessov NS, Dixon MP, Eckenstein F (1997) Monofilament intraluminal middle cerebral artery occlusion in the mouse. Neurol Res 19: 641–648PubMedGoogle Scholar
  2. 2.
    Gravanis I, Tsirka SE (2008) Tissue-type plasminogen activator as a therapeutic target in stroke. Expert Opin Ther Targets 12: 159–170PubMedCrossRefGoogle Scholar
  3. 3.
    Hailer NP (2008) Immunosuppression after traumatic or ischemic CNS damage: it is neuroprotective and illuminates the role of microglial cells. Prog Neurobiol 84: 211–233PubMedCrossRefGoogle Scholar
  4. 4.
    Hanisch UK, Kettenmann H (2007) Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10: 1387–1394PubMedCrossRefGoogle Scholar
  5. 5.
    Heppner FL, Greter M, Marino D, Falsig J, Raivich G, Hövelmeyer N, Waisman A, Rülicke T, Prinz M, Priller J, Becher B, Aguzzi A (2005) Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat Med 11: 146–152PubMedCrossRefGoogle Scholar
  6. 6.
    Kreutzberg GW (1995) Microglia, the first line of defense in brain pathologies. Arzneimittelforschung 45: 357–360PubMedGoogle Scholar
  7. 7.
    Kreutzberg GW (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19: 312–318PubMedCrossRefGoogle Scholar
  8. 8.
    Sheehan JJ, Tsirka SE (2005) Fibrin-modifying serine proteases thrombin, tPA, and plasmin in ischemic stroke: a review. Glia 50: 340–350PubMedCrossRefGoogle Scholar
  9. 9.
    Thiex R, Küker W, Müller HD, Rohde I, Schröder JM, Gilsbach JM, Rohde V (2003) The long-term effect of recombinant tissue-plas-minogen-activator (rt-PA) on edema formation in a large-animal model of intracerebral hemorrhage. Neurol Res 25: 254–262PubMedCrossRefGoogle Scholar
  10. 10.
    Thiex R, Mayfrank L, Rohde V, Gilsbach JM, Tsirka SA (2004) The role of endogenous versus exogenous tPA on edema formation in murine ICH. Exp Neurol 189: 25–32PubMedCrossRefGoogle Scholar
  11. 11.
    Wang J, Doré S (2007) Inflammation after intracerebral hemorrhage. J Cereb Blood Flow Metab 27: 894–908PubMedCrossRefGoogle Scholar
  12. 12.
    Wang J, Tsirka SE (2005) Neuroprotection by inhibition of matrix metalloproteinases in a mouse model of intracerebral haemorrhage. Brain 128: 1622–1633PubMedCrossRefGoogle Scholar
  13. 13.
    Wang J, Tsirka SE (2005) Tuftsin fragment 1-3 is beneficial when delivered after the induction of intracerebral hemorrhage. Stroke 36: 613–618PubMedCrossRefGoogle Scholar
  14. 14.
    Wang J, Rogove AD, Tsirka AE, Tsirka SE (2003) Protective role of tuftsin fragment 1-3 in an animal model of intracerebral hemorrhage. Ann Neurol 54: 655–664PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Z. Gao
    • 1
  • J. Wang
    • 1
  • R. Thiex
    • 1
  • A. D. Rogove
    • 1
  • F. L. Heppner
    • 2
  • S. E. Tsirka
    • 1
  1. 1.Department of Pharmacological SciencesStony Brook UniversityStony BrookUSA
  2. 2.Institute of NeuropathologyCharité — Universitätsmedizin BerlinBerlinGermany

Personalised recommendations